Clinical Trials and registries to prevent blindness for Macular Disease

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1103406

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Injection of drugs into the eye is an unprecedented breakthrough in the treatment of macular diseases, however many questions must be addressed for our patients with diabetic retinopathy and macular degeneration to reap the full benefits. My clinical research unit will conduct our own clinical trials, such as testing a new laser that has never been used in the retina. My observational studies unit will track “real world” outcomes of treatment of retinal disease in a large group of Australians.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2020

Funding Scheme: Practitioner Fellowships

Funding Amount: $467,961.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Ophthalmology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

diabetic retinopathy | macular degeneration | ophthalmology | outcomes research | randomised controlled trial (RCT)

Related Links